Literature DB >> 21841857

Stroke prevention in nonvalvular atrial fibrillation.

Leila Ganjehei1, Ali Massumi, Mehdi Razavi, Abdi Rasekh.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21841857      PMCID： PMC3147190     

Source DB:  PubMed          Journal:  Tex Heart Inst J        ISSN： 0730-2347


× No keyword cloud information.
  24 in total

1.  A comparison of rate control and rhythm control in patients with atrial fibrillation.

Authors:  D G Wyse; A L Waldo; J P DiMarco; M J Domanski; Y Rosenberg; E B Schron; J C Kellen; H L Greene; M C Mickel; J E Dalquist; S D Corley
Journal:  N Engl J Med       Date:  2002-12-05       Impact factor: 91.245

2.  INR variability in atrial fibrillation: a risk model for cerebrovascular events.

Authors:  Philippe Amouyel; Patrick Mismetti; Lars K Langkilde; Guillermo Jasso-Mosqueda; Karin Nelander; Hervé Lamarque
Journal:  Eur J Intern Med       Date:  2008-06-25       Impact factor: 4.487

3.  The left atrial appendage: our most lethal human attachment! Surgical implications.

Authors:  W D Johnson; A K Ganjoo; C D Stone; R C Srivyas; M Howard
Journal:  Eur J Cardiothorac Surg       Date:  2000-06       Impact factor: 4.191

4.  Dabigatran versus warfarin in patients with atrial fibrillation.

Authors:  Stuart J Connolly; Michael D Ezekowitz; Salim Yusuf; John Eikelboom; Jonas Oldgren; Amit Parekh; Janice Pogue; Paul A Reilly; Ellison Themeles; Jeanne Varrone; Susan Wang; Marco Alings; Denis Xavier; Jun Zhu; Rafael Diaz; Basil S Lewis; Harald Darius; Hans-Christoph Diener; Campbell D Joyner; Lars Wallentin
Journal:  N Engl J Med       Date:  2009-08-30       Impact factor: 91.245

5.  Stroke severity in atrial fibrillation. The Framingham Study.

Authors:  H J Lin; P A Wolf; M Kelly-Hayes; A S Beiser; C S Kase; E J Benjamin; R B D'Agostino
Journal:  Stroke       Date:  1996-10       Impact factor: 7.914

6.  Transcatheter left atrial appendage occlusion with Amplatzer devices to obviate anticoagulation in patients with atrial fibrillation.

Authors:  Bernhard Meier; Igor Palacios; Stephan Windecker; Martin Rotter; Qi-Ling Cao; David Keane; Carlos E Ruiz; Ziyad M Hijazi
Journal:  Catheter Cardiovasc Interv       Date:  2003-11       Impact factor: 2.692

Review 7.  Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation.

Authors:  J L Blackshear; J A Odell
Journal:  Ann Thorac Surg       Date:  1996-02       Impact factor: 4.330

8.  Thoracoscopic obliteration of the left atrial appendage: potential for stroke reduction?

Authors:  J A Odell; J L Blackshear; E Davies; W J Byrne; C F Kollmorgen; W D Edwards; T A Orszulak
Journal:  Ann Thorac Surg       Date:  1996-02       Impact factor: 4.330

Review 9.  Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited.

Authors:  Timothy Watson; Eduard Shantsila; Gregory Y H Lip
Journal:  Lancet       Date:  2009-01-10       Impact factor: 79.321

10.  Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial.

Authors:  David R Holmes; Vivek Y Reddy; Zoltan G Turi; Shephal K Doshi; Horst Sievert; Maurice Buchbinder; Christopher M Mullin; Peter Sick
Journal:  Lancet       Date:  2009-08-15       Impact factor: 79.321
View more
  2 in total

1.  Non-pharmacological therapy for atrial fibrillation: managing the left atrial appendage.

Authors:  Sushil Allen Luis; Damian Roper; Alexander Incani; Karl Poon; Haris Haqqani; Darren L Walters
Journal:  Cardiol Res Pract       Date:  2012-05-15       Impact factor: 1.866

Review 2.  Stroke risk evaluation for patients with atrial fibrillation: Insights from left atrial appendage.

Authors:  Runxin Fang; Yang Li; Jun Wang; Zidun Wang; John Allen; Chi Keong Ching; Liang Zhong; Zhiyong Li
Journal:  Front Cardiovasc Med       Date:  2022-08-22
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.